Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 37 | 12/21/12 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13/21/13 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11/17/11 |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/17/15 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 20/17/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/17/15 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02/16/02 |
Daniel Kazado
BRD | Director/Board Member | 59 | 10/13/10 |
Jeff Paley
BRD | Director/Board Member | 55 | 23/16/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,713 | 0 | 0 | 100.00 % |
Stock B | 1 | 172,878,093 | 172,878,093 ( 100.00 %) | 0 |
Company contact information
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.com![address Immune Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/34629737.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+55.32% | 82TCr | |
+43.96% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.31% | 24TCr | |
+2.29% | 22TCr | |
+12.96% | 22TCr | |
+8.48% | 17TCr |